Literature DB >> 21512731

High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma.

Dai Chihara1, Yasuhiro Oki2, Hiroshi Onoda1, Hirofumi Taji1, Kazuhito Yamamoto1, Tsuneo Tamaki3, Yasuo Morishima1.   

Abstract

FDG-PET scan plays an important role in response assessment in diffuse large B cell lymphoma (DLBCL). In this study, we evaluated the prognostic value of maximum standard uptake (SUVmax) on pretreatment PET scan in DLBCL. Among 169 patients with DLBCL newly diagnosed and treated with R-CHOP between 2003 and 2008, 110 patients who had undergone pretreatment PET scan in single institute using an identical protocol were reviewed and analyzed. SUVmax at the predominant lesion on PET scan and other patient characteristics were evaluated for their association with complete response (CR) rate, overall survival (OS) and progression-free survival (PFS). The median SUVmax was 18.1 (2.0-36.4). There was no significant association between high SUV and other characteristics with the exception of PS ≥ 2 and Ki-67. Multivariate analysis revealed the independent association between high SUVmax and lower CR rate. The 3-year PFS rates in patients with SUV < 30 and those with SUV ≥ 30 were 78 and 51%, respectively (p = 0.06). The 3-year OS rates were 86 and 71%, respectively (p = 0.03). Multivariate analysis revealed that high SUVmax is a significant poor prognostic factor for both PFS and OS, independent of IPI. We showed the important prognostic value of pretreatment SUVmax of PET scan in DLBCL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21512731     DOI: 10.1007/s12185-011-0822-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  25 in total

1.  Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling.

Authors:  R Boellaard; A van Lingen; A A Lammertsma
Journal:  J Nucl Med       Date:  2001-05       Impact factor: 10.057

2.  Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake.

Authors:  Martin Hutchings; Annika Loft; Mads Hansen; Elisabeth Ralfkiaer; Lena Specht
Journal:  Hematol Oncol       Date:  2006-09       Impact factor: 5.271

3.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

4.  Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.

Authors:  Malik E Juweid; Gregory A Wiseman; Julie M Vose; Justine M Ritchie; Yusuf Menda; James E Wooldridge; Felix M Mottaghy; Eric M Rohren; Norbert M Blumstein; Alan Stolpen; Brian K Link; Sven N Reske; Michael M Graham; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2005-04-18       Impact factor: 44.544

Review 5.  Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis.

Authors:  LingLing Pan; Ping Gu; Gang Huang; HuiPing Xue; ShuQi Wu
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-09       Impact factor: 2.566

6.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

7.  A predictive model for aggressive non-Hodgkin's lymphoma.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

8.  New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.

Authors:  Bruce D Cheson
Journal:  Radiol Clin North Am       Date:  2008-03       Impact factor: 2.303

9.  The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.

Authors:  Angela van Baardwijk; Christophe Dooms; Robert Jan van Suylen; Erik Verbeken; Monique Hochstenbag; Cary Dehing-Oberije; Dennis Rupa; Silvia Pastorekova; Sigrid Stroobants; Ulrich Buell; Philippe Lambin; Johan Vansteenkiste; Dirk De Ruysscher
Journal:  Eur J Cancer       Date:  2007-05-23       Impact factor: 9.162

10.  Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.

Authors:  K Spaepen; S Stroobants; P Dupont; P Vandenberghe; J Thomas; T de Groot; J Balzarini; C De Wolf-Peeters; L Mortelmans; G Verhoef
Journal:  Ann Oncol       Date:  2002-09       Impact factor: 32.976

View more
  33 in total

1.  Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission.

Authors:  Silvia Morbelli; Selene Capitanio; Fabrizio De Carli; Francesca Bongioanni; Enrico De Astis; Maurizio Miglino; Maria Teresa Verardi; Ambra Buschiazzo; Francesco Fiz; Cecilia Marini; Elena Pomposelli; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-19       Impact factor: 9.236

2.  Predictive value of 18F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trial.

Authors:  Stéphanie Becker; Thomas Vermeulin; Anne-Ségolène Cottereau; Nicolas Boissel; Pierre Vera; Stéphane Lepretre
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-21       Impact factor: 9.236

3.  Prognostic value of metabolic tumour volume on baseline 18F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI.

Authors:  Qaid Ahmed Shagera; Gi Jeong Cheon; Youngil Koh; Min Young Yoo; Keon Wook Kang; Dong Soo Lee; E Edmund Kim; Sung-Soo Yoon; June-Key Chung
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-04-02       Impact factor: 9.236

4.  The role of positron emission tomography/CT imaging in head and neck cancer patients after radical chemoradiotherapy.

Authors:  J M Sherriff; B Ogunremi; S Colley; P Sanghera; A Hartley
Journal:  Br J Radiol       Date:  2012-06-27       Impact factor: 3.039

5.  SUV navigator enables rapid [18F]-FDG PET/CT image interpretation compared with 2D ROI and 3D VOI evaluations.

Authors:  Atsutaka Okizaki; Michihiro Nakayama; Shunta Ishitoya; Kaori Nakajima; Masaaki Yamashina; Tamio Aburano; Koji Takahashi
Journal:  Jpn J Radiol       Date:  2017-05-11       Impact factor: 2.374

6.  Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation.

Authors:  Naresh Jegadeesh; Raj Rajpara; Natia Esiashvili; Zheng Shi; Yuan Liu; Derrick Okwan-Duodu; Christopher R Flowers; Mohammad K Khan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-05-01       Impact factor: 7.038

7.  Predictive value of F-18 FDG PET/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants.

Authors:  Mixue Xie; Kefei Wu; Yan Liu; Qi Jiang; Yanhui Xie
Journal:  Med Oncol       Date:  2014-12-16       Impact factor: 3.064

8.  The Role of (18)F-FDG PET/CT as a Prognostic Factor in Patients with Synovial Sarcoma.

Authors:  Kyoung Jin Chang; Ilhan Lim; Joon Yeun Park; A Ra Jo; Chang Bae Kong; Won Seok Song; Wan Hyeong Jo; Soo Yong Lee; Jae Soo Koh; Byung Il Kim; Chang Woon Choi; Sang Moo Lim
Journal:  Nucl Med Mol Imaging       Date:  2014-10-30

9.  Predictive value of pretreatment positron emission tomography/computed tomography in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.

Authors:  Bing Bai; Hui-Qiang Huang; Qi-Chun Cai; Wei Fan; Xiao-Xiao Wang; Xu Zhang; Ze-Xiao Lin; Yan Gao; Yun-Fei Xia; Ying Guo; Qing-Qing Cai; Wen-Qi Jiang; Tong-Yu Lin
Journal:  Med Oncol       Date:  2013-01-18       Impact factor: 3.064

10.  Evaluating the Predictive Ability of Initial Staging F-18 FDG PET/CT for the Prognosis of Non-Hodgkin Malignant Lymphoma Patients Who Underwent Stem Cell Transplantation.

Authors:  Yun Soo Park; Seok Mo Lee; Ji Sun Park; Sang Kyun Bae; Hye-Kyung Shim; Won-Sik Lee; Sang-Min Lee
Journal:  Nucl Med Mol Imaging       Date:  2017-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.